Welcome to AstraZeneca
As one of the world's leading pharmaceutical companies, our business is focused on turning good ideas into innovative, effective medicines that make a real difference in important areas of healthcare.-
Our research
In the fight against human disease, we focus on six disease areas where we believe our skills and experience can make the most difference:
-
Latest news collapse
-
24 December 2008
AstraZeneca Receives FDA Complete Response Letter on Seroquel XR for Major Depressive Disorder
AstraZeneca today announced the company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) asking for additional information for the supplemental New Drug Application for SEROQUEL XR (quetiapine fumarate) Extended Release Tablets for the treatment of Major Depressive Disorder (MDD) in adult patients.
Did you know expand
Most popular topics expand
-
24 December 2008
AstraZeneca Receives FDA Complete Response Letter on Seroquel XR for Major Depressive Disorder
